Dr Reddys Laboratories Share Price Today - Live Blog for October 28, 2025

Dr Reddys Laboratories Ltd stock price decreased by -0.03%, with the current market value at ₹1,290.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.12% upswing and is currently trading at ₹1,292.40, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.53%, and as of now, it's trading at ₹1,290.95 per share. This upward trajectory is attracting keen interest from investors.

After a significant 0.02% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,284.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.18% increase and currently trading at ₹1,284.95 per share. Investors are taking notice of this upward momentum.

The share price of Dr Reddys Laboratories Ltd plunged by -0.00%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,283.25, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.03%, signalling a challenging period. Currently trading at ₹1,282.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has fallen by -0.08%, a situation worth noting. At present, the stock is trading at ₹1,283.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6900, while the industry PE ratio is 34.9088.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.03%. At this moment, it's actively trading at ₹1,284.75, presenting an enticing opportunity for those in the market.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.04% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,284.90 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd plunged by -0.11%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,284.35, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's share price rallied by 0.03%, reaching the current market price of ₹1,284.95. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd observed a remarkable 0.10% surge in its share price and is presently trading at ₹1,282.25. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd experienced a substantial 0.02% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,281.45, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.12%, a situation worth noting. At present, the stock is trading at ₹1,281.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6900, while the industry PE ratio is 34.9088.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.16%, reaching a current market price of ₹1,282.90. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a significant 0.18% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,284.85 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.12% surge in its share price and is presently trading at ₹1,281.60. The increased investor interest is driving this surge.

After a significant 0.27% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,280.60 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.04% upswing, and it's currently trading at ₹1,277.90 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,277.40, and market participants are assessing the implications. The stock has a PE ratio of 18.6900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,278.00, and market participants are assessing the implications. The stock has a PE ratio of 18.6900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a -0.18% dip in its share price and is currently trading at ₹1,279.40. The stock has a PE ratio of 18.6900, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is facing a -0.47% decline and is currently trading at ₹1,282.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.35%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,289.00 per share.

Dr Reddys Laboratories Ltd share price has declined by -0.11%, and it's currently trading at ₹1,283.60. The stock maintains a PE of 18.6900, while the industry PE is 34.9088, prompting discussions about its valuation.